Li, F., Chen, Y., Zhuang, H., Pei, R., Lu, Y., chen, D., . . . Lu, Y. (2025). A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targeting. Discover Oncology, 16(1), 1. https://doi.org/10.1007/s12672-025-02242-7
Chicago-referens (17:e uppl.)Li, Fenglin, et al. "A Combination of Dihydroartemisinin and Venetoclax Enhances Antitumor Effect in AML via C-MYC/BCL-XL/MCL-1 Triple Targeting." Discover Oncology 16, no. 1 (2025): 1. https://doi.org/10.1007/s12672-025-02242-7.
MLA-referens (9:e uppl.)Li, Fenglin, et al. "A Combination of Dihydroartemisinin and Venetoclax Enhances Antitumor Effect in AML via C-MYC/BCL-XL/MCL-1 Triple Targeting." Discover Oncology, vol. 16, no. 1, 2025, p. 1, https://doi.org/10.1007/s12672-025-02242-7.
